Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastric Bypass | 11 | 2022 | 812 | 3.470 |
Why?
|
Bone Density | 32 | 2023 | 3468 | 3.050 |
Why?
|
Osteoporosis | 14 | 2023 | 1580 | 2.650 |
Why?
|
Obesity, Morbid | 7 | 2020 | 1213 | 1.780 |
Why?
|
Absorptiometry, Photon | 18 | 2023 | 1725 | 1.570 |
Why?
|
Bariatric Surgery | 6 | 2020 | 952 | 1.540 |
Why?
|
Bone Diseases, Metabolic | 5 | 2022 | 417 | 1.520 |
Why?
|
Gastroplasty | 3 | 2020 | 142 | 1.320 |
Why?
|
Bone Remodeling | 6 | 2018 | 575 | 1.150 |
Why?
|
Fractures, Bone | 6 | 2021 | 1947 | 1.150 |
Why?
|
Osteoporosis, Postmenopausal | 4 | 2021 | 386 | 1.100 |
Why?
|
Radius | 9 | 2023 | 422 | 1.040 |
Why?
|
Postmenopause | 9 | 2021 | 2461 | 1.010 |
Why?
|
Gastrectomy | 3 | 2021 | 663 | 0.990 |
Why?
|
Libido | 3 | 2020 | 121 | 0.940 |
Why?
|
Bone and Bones | 11 | 2023 | 2575 | 0.910 |
Why?
|
Osteonecrosis | 2 | 2022 | 227 | 0.840 |
Why?
|
Bone Density Conservation Agents | 6 | 2022 | 773 | 0.820 |
Why?
|
Goserelin | 3 | 2020 | 129 | 0.780 |
Why?
|
Teriparatide | 2 | 2014 | 225 | 0.740 |
Why?
|
Testosterone | 5 | 2020 | 2420 | 0.730 |
Why?
|
Adipose Tissue | 5 | 2021 | 3279 | 0.700 |
Why?
|
Histamine H2 Antagonists | 2 | 2011 | 165 | 0.660 |
Why?
|
Bone Resorption | 3 | 2018 | 723 | 0.590 |
Why?
|
Tibia | 8 | 2023 | 1077 | 0.590 |
Why?
|
Osteoporotic Fractures | 3 | 2021 | 401 | 0.560 |
Why?
|
Bone Marrow | 2 | 2016 | 2948 | 0.550 |
Why?
|
Eunuchism | 1 | 2016 | 19 | 0.550 |
Why?
|
Body Composition | 9 | 2019 | 2401 | 0.550 |
Why?
|
Insulin Resistance | 3 | 2020 | 3864 | 0.530 |
Why?
|
Bone Diseases | 1 | 2019 | 416 | 0.530 |
Why?
|
Subcutaneous Fat | 2 | 2017 | 391 | 0.520 |
Why?
|
Proton Pump Inhibitors | 2 | 2011 | 526 | 0.500 |
Why?
|
Intra-Abdominal Fat | 2 | 2017 | 591 | 0.450 |
Why?
|
Adiposity | 2 | 2020 | 1807 | 0.440 |
Why?
|
Ferric Compounds | 4 | 2020 | 374 | 0.440 |
Why?
|
Pelvic Bones | 3 | 2020 | 265 | 0.440 |
Why?
|
Parathyroid Hormone | 4 | 2016 | 1801 | 0.430 |
Why?
|
Magnetics | 4 | 2021 | 606 | 0.420 |
Why?
|
Tomography, X-Ray Computed | 9 | 2019 | 20129 | 0.420 |
Why?
|
Obesity | 8 | 2023 | 12745 | 0.390 |
Why?
|
Magnetite Nanoparticles | 3 | 2018 | 321 | 0.380 |
Why?
|
Intestines | 1 | 2020 | 1924 | 0.370 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2012 | 838 | 0.350 |
Why?
|
Energy Metabolism | 1 | 2020 | 2899 | 0.330 |
Why?
|
Middle Aged | 39 | 2021 | 213383 | 0.290 |
Why?
|
Pandemics | 4 | 2022 | 8388 | 0.290 |
Why?
|
Diagnostic Imaging | 5 | 2020 | 3507 | 0.260 |
Why?
|
Body Mass Index | 4 | 2019 | 12720 | 0.260 |
Why?
|
Humans | 70 | 2023 | 744343 | 0.260 |
Why?
|
Spine | 3 | 2018 | 1144 | 0.250 |
Why?
|
Hip | 2 | 2017 | 257 | 0.250 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5319 | 0.250 |
Why?
|
Oxytocin | 2 | 2020 | 394 | 0.250 |
Why?
|
Estradiol | 4 | 2017 | 2020 | 0.240 |
Why?
|
Male | 37 | 2022 | 350118 | 0.230 |
Why?
|
Lumbar Vertebrae | 4 | 2022 | 1848 | 0.230 |
Why?
|
Hip Fractures | 3 | 2018 | 955 | 0.230 |
Why?
|
Female | 43 | 2023 | 380194 | 0.230 |
Why?
|
Medicare | 2 | 2019 | 6566 | 0.230 |
Why?
|
Propensity Score | 3 | 2020 | 1781 | 0.230 |
Why?
|
Cell Tracking | 2 | 2021 | 145 | 0.210 |
Why?
|
Peptide YY | 1 | 2022 | 130 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Fanconi Syndrome | 1 | 2022 | 35 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 1 | 2014 | 3386 | 0.200 |
Why?
|
Aging | 1 | 2020 | 8664 | 0.200 |
Why?
|
Practice Guidelines as Topic | 3 | 2013 | 7279 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 11725 | 0.190 |
Why?
|
Adult | 29 | 2021 | 214055 | 0.190 |
Why?
|
Weight Loss | 3 | 2019 | 2622 | 0.190 |
Why?
|
Femur Neck | 2 | 2022 | 309 | 0.190 |
Why?
|
Hypopituitarism | 2 | 2020 | 254 | 0.190 |
Why?
|
X-Ray Microtomography | 1 | 2022 | 428 | 0.190 |
Why?
|
Postoperative Complications | 2 | 2020 | 15295 | 0.190 |
Why?
|
Diabetes Insipidus, Neurogenic | 1 | 2020 | 19 | 0.180 |
Why?
|
Penile Erection | 1 | 2020 | 97 | 0.180 |
Why?
|
Anti-Mullerian Hormone | 1 | 2022 | 402 | 0.180 |
Why?
|
Muscle Strength | 2 | 2013 | 592 | 0.170 |
Why?
|
Anorexia Nervosa | 2 | 2019 | 1286 | 0.170 |
Why?
|
Gels | 1 | 2020 | 427 | 0.170 |
Why?
|
Body Fat Distribution | 1 | 2020 | 244 | 0.170 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 666 | 0.170 |
Why?
|
Congresses as Topic | 2 | 2013 | 764 | 0.160 |
Why?
|
Risk Assessment | 2 | 2019 | 23338 | 0.160 |
Why?
|
Fractures, Spontaneous | 1 | 2020 | 230 | 0.160 |
Why?
|
Vasopressins | 1 | 2020 | 370 | 0.160 |
Why?
|
Models, Animal | 2 | 2016 | 2171 | 0.160 |
Why?
|
Administration, Cutaneous | 1 | 2020 | 711 | 0.160 |
Why?
|
Computer Simulation | 1 | 2012 | 6196 | 0.160 |
Why?
|
Diphosphonates | 2 | 2022 | 623 | 0.160 |
Why?
|
Aged | 18 | 2022 | 163280 | 0.150 |
Why?
|
Thrombophilia | 1 | 2020 | 305 | 0.150 |
Why?
|
Central Cord Syndrome | 1 | 2016 | 4 | 0.150 |
Why?
|
Risk Factors | 10 | 2021 | 72290 | 0.150 |
Why?
|
Mass Screening | 1 | 2012 | 5255 | 0.140 |
Why?
|
Unnecessary Procedures | 1 | 2020 | 432 | 0.140 |
Why?
|
Hyperthermia, Induced | 1 | 2020 | 403 | 0.140 |
Why?
|
Hydroxycholecalciferols | 1 | 2015 | 44 | 0.140 |
Why?
|
Galactose | 1 | 2017 | 306 | 0.130 |
Why?
|
Aerosols | 1 | 2018 | 625 | 0.130 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1105 | 0.130 |
Why?
|
Dextrans | 1 | 2017 | 595 | 0.130 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1018 | 0.130 |
Why?
|
Treatment Outcome | 7 | 2020 | 63114 | 0.120 |
Why?
|
Vitamin D Deficiency | 2 | 2021 | 1343 | 0.120 |
Why?
|
Rare Diseases | 1 | 2019 | 553 | 0.120 |
Why?
|
Contrast Media | 3 | 2018 | 5300 | 0.120 |
Why?
|
Acromegaly | 1 | 2017 | 346 | 0.120 |
Why?
|
Cross-Sectional Studies | 6 | 2020 | 25043 | 0.120 |
Why?
|
United States | 12 | 2021 | 69872 | 0.120 |
Why?
|
Postprandial Period | 1 | 2015 | 292 | 0.120 |
Why?
|
Menopause | 1 | 2022 | 1626 | 0.120 |
Why?
|
Tibial Fractures | 1 | 2017 | 269 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10943 | 0.120 |
Why?
|
Porosity | 1 | 2014 | 362 | 0.120 |
Why?
|
Home Care Services | 1 | 2020 | 606 | 0.120 |
Why?
|
Glycosylation | 1 | 2017 | 1126 | 0.120 |
Why?
|
Estrogen Replacement Therapy | 1 | 2020 | 1203 | 0.110 |
Why?
|
Abdominal Fat | 1 | 2015 | 223 | 0.110 |
Why?
|
Continuity of Patient Care | 1 | 2020 | 1049 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2015 | 21746 | 0.110 |
Why?
|
Health Resources | 1 | 2019 | 911 | 0.110 |
Why?
|
Hormones | 1 | 2016 | 889 | 0.110 |
Why?
|
Bed Rest | 1 | 2012 | 84 | 0.110 |
Why?
|
Vitamin D | 3 | 2021 | 3223 | 0.100 |
Why?
|
Patient Admission | 2 | 2019 | 1380 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4933 | 0.100 |
Why?
|
Radius Fractures | 1 | 2017 | 501 | 0.100 |
Why?
|
Mice, Inbred C57BL | 2 | 2022 | 21827 | 0.100 |
Why?
|
Societies, Medical | 2 | 2013 | 3743 | 0.100 |
Why?
|
Phantoms, Imaging | 3 | 2019 | 2480 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1855 | 0.100 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13989 | 0.100 |
Why?
|
Procollagen | 1 | 2011 | 185 | 0.100 |
Why?
|
Incidence | 3 | 2019 | 20947 | 0.100 |
Why?
|
Osteocalcin | 1 | 2011 | 273 | 0.100 |
Why?
|
Recurrence | 2 | 2020 | 8340 | 0.090 |
Why?
|
Young Adult | 10 | 2023 | 56430 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2016 | 496 | 0.090 |
Why?
|
Anti-Ulcer Agents | 1 | 2011 | 119 | 0.090 |
Why?
|
Polysaccharides | 1 | 2017 | 1053 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6489 | 0.090 |
Why?
|
Molecular Imaging | 1 | 2017 | 828 | 0.090 |
Why?
|
Cell Count | 1 | 2014 | 1856 | 0.090 |
Why?
|
Pilot Projects | 2 | 2020 | 8324 | 0.090 |
Why?
|
Animals | 9 | 2022 | 168757 | 0.090 |
Why?
|
Pharmaceutical Preparations | 1 | 2018 | 1071 | 0.090 |
Why?
|
Estrogens | 1 | 2017 | 1566 | 0.090 |
Why?
|
Prospective Studies | 5 | 2022 | 53288 | 0.090 |
Why?
|
Follow-Up Studies | 5 | 2019 | 39050 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2459 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1972 | 0.080 |
Why?
|
Vision, Low | 1 | 2011 | 168 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6538 | 0.080 |
Why?
|
Dietary Supplements | 1 | 2021 | 3297 | 0.080 |
Why?
|
Calcium | 3 | 2012 | 5756 | 0.080 |
Why?
|
Nephritis | 1 | 2009 | 159 | 0.080 |
Why?
|
Time Factors | 4 | 2020 | 40075 | 0.080 |
Why?
|
Fasting | 1 | 2014 | 1593 | 0.080 |
Why?
|
Collagen Type I | 1 | 2011 | 592 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3719 | 0.080 |
Why?
|
Genetic Markers | 2 | 2012 | 2634 | 0.080 |
Why?
|
Cholesterol, HDL | 1 | 2015 | 1814 | 0.080 |
Why?
|
Neoplasms | 3 | 2023 | 21683 | 0.080 |
Why?
|
Choroidal Neovascularization | 1 | 2011 | 343 | 0.080 |
Why?
|
Hip Joint | 1 | 2014 | 1002 | 0.080 |
Why?
|
Calcinosis | 1 | 2016 | 1499 | 0.080 |
Why?
|
Body Weight | 2 | 2016 | 4669 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2020 | 57776 | 0.070 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.070 |
Why?
|
Blindness | 1 | 2011 | 617 | 0.070 |
Why?
|
Cyclic AMP | 1 | 2010 | 1472 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3760 | 0.070 |
Why?
|
Gastrointestinal Agents | 1 | 2011 | 494 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12026 | 0.070 |
Why?
|
Canada | 1 | 2011 | 2065 | 0.070 |
Why?
|
Cholesterol | 1 | 2015 | 2917 | 0.070 |
Why?
|
Premenopause | 2 | 2022 | 1033 | 0.070 |
Why?
|
Femur | 1 | 2012 | 1297 | 0.060 |
Why?
|
Cell Lineage | 1 | 2014 | 2504 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12354 | 0.060 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 4266 | 0.060 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2012 | 1184 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2017 | 4560 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2038 | 0.060 |
Why?
|
Cohort Studies | 5 | 2021 | 40561 | 0.060 |
Why?
|
Spinal Fractures | 1 | 2011 | 696 | 0.060 |
Why?
|
Europe | 1 | 2011 | 3339 | 0.060 |
Why?
|
Medication Adherence | 1 | 2016 | 2063 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2012 | 2916 | 0.060 |
Why?
|
Macular Degeneration | 1 | 2011 | 980 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3870 | 0.060 |
Why?
|
Mice | 5 | 2022 | 81183 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15165 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2015 | 3778 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4149 | 0.050 |
Why?
|
Mexican Americans | 1 | 2003 | 166 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2020 | 5034 | 0.050 |
Why?
|
Sickness Impact Profile | 1 | 2003 | 302 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2266 | 0.050 |
Why?
|
Aromatase Inhibitors | 2 | 2017 | 491 | 0.050 |
Why?
|
Tooth Extraction | 1 | 2022 | 222 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2016 | 2327 | 0.050 |
Why?
|
Multiple Sclerosis | 1 | 2016 | 3079 | 0.050 |
Why?
|
Bicarbonates | 1 | 2022 | 313 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4665 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7659 | 0.050 |
Why?
|
Alendronate | 1 | 2021 | 171 | 0.050 |
Why?
|
Blood Glucose | 1 | 2014 | 6256 | 0.050 |
Why?
|
Patient Compliance | 1 | 2010 | 2684 | 0.050 |
Why?
|
Sex Factors | 2 | 2017 | 10397 | 0.040 |
Why?
|
Glioblastoma | 1 | 2015 | 3481 | 0.040 |
Why?
|
Vision, Ocular | 1 | 2003 | 464 | 0.040 |
Why?
|
Peptides | 1 | 2011 | 4409 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5097 | 0.040 |
Why?
|
Retrospective Studies | 5 | 2019 | 77449 | 0.040 |
Why?
|
Odds Ratio | 1 | 2011 | 9849 | 0.040 |
Why?
|
Insurance Claim Review | 2 | 2016 | 720 | 0.040 |
Why?
|
Durapatite | 1 | 2019 | 161 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5751 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2020 | 8863 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2020 | 319 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2009 | 2104 | 0.040 |
Why?
|
Four-Dimensional Computed Tomography | 1 | 2018 | 145 | 0.040 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 246 | 0.040 |
Why?
|
Spin Labels | 1 | 2018 | 332 | 0.040 |
Why?
|
Fertility Agents, Female | 1 | 2017 | 99 | 0.040 |
Why?
|
Perfusion Imaging | 1 | 2018 | 195 | 0.040 |
Why?
|
T-Lymphocytes | 1 | 2014 | 10180 | 0.040 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2017 | 129 | 0.040 |
Why?
|
Calcium, Dietary | 1 | 2019 | 526 | 0.030 |
Why?
|
Biomedical Technology | 1 | 2018 | 220 | 0.030 |
Why?
|
Amino Acids | 1 | 2022 | 1736 | 0.030 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2017 | 275 | 0.030 |
Why?
|
Laminectomy | 1 | 2016 | 234 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 5987 | 0.030 |
Why?
|
Leuprolide | 1 | 2017 | 321 | 0.030 |
Why?
|
Adolescent | 5 | 2023 | 85781 | 0.030 |
Why?
|
Carbocyanines | 1 | 2015 | 174 | 0.030 |
Why?
|
Rats, Inbred F344 | 1 | 2016 | 862 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2011 | 9274 | 0.030 |
Why?
|
Hydrodynamics | 1 | 2015 | 158 | 0.030 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 405 | 0.030 |
Why?
|
Psychometrics | 1 | 2003 | 3002 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 681 | 0.030 |
Why?
|
Optics and Photonics | 1 | 2015 | 321 | 0.030 |
Why?
|
Women's Health | 1 | 2022 | 2034 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2015 | 712 | 0.030 |
Why?
|
Angiography | 1 | 2018 | 1639 | 0.030 |
Why?
|
Head-Down Tilt | 1 | 2012 | 64 | 0.030 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2012 | 115 | 0.030 |
Why?
|
Human Growth Hormone | 1 | 2017 | 683 | 0.030 |
Why?
|
Eating | 1 | 2019 | 1536 | 0.030 |
Why?
|
Postural Balance | 1 | 2016 | 620 | 0.030 |
Why?
|
Equipment Design | 1 | 2020 | 3582 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2016 | 1100 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2013 | 431 | 0.020 |
Why?
|
Phosphorus | 1 | 2012 | 338 | 0.020 |
Why?
|
Weight-Bearing | 1 | 2013 | 515 | 0.020 |
Why?
|
Forecasting | 1 | 2020 | 2951 | 0.020 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2017 | 1205 | 0.020 |
Why?
|
Cervical Vertebrae | 1 | 2016 | 975 | 0.020 |
Why?
|
Databases, Factual | 2 | 2019 | 7729 | 0.020 |
Why?
|
Community Pharmacy Services | 1 | 2009 | 46 | 0.020 |
Why?
|
Androgens | 1 | 2017 | 1281 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1182 | 0.020 |
Why?
|
Body Size | 1 | 2012 | 461 | 0.020 |
Why?
|
Nanotechnology | 1 | 2015 | 710 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
Accidental Falls | 1 | 2016 | 1062 | 0.020 |
Why?
|
Temperature | 1 | 2015 | 2206 | 0.020 |
Why?
|
Physical Fitness | 1 | 2012 | 733 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 2274 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3158 | 0.020 |
Why?
|
Medical Records Systems, Computerized | 1 | 2012 | 1205 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2015 | 2050 | 0.020 |
Why?
|
Administration, Oral | 1 | 2012 | 3913 | 0.020 |
Why?
|
Nanoparticles | 1 | 2016 | 1905 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2009 | 1681 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14722 | 0.010 |
Why?
|
Los Angeles | 1 | 2003 | 238 | 0.010 |
Why?
|
Visual Acuity | 1 | 2011 | 2530 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12959 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18370 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2009 | 2708 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2015 | 8949 | 0.010 |
Why?
|
Insurance, Health | 1 | 2009 | 2494 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 11124 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9239 | 0.010 |
Why?
|
Vision Disorders | 1 | 2003 | 1058 | 0.010 |
Why?
|
Child | 1 | 2022 | 77709 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2009 | 4251 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2003 | 2418 | 0.010 |
Why?
|
Language | 1 | 2003 | 1471 | 0.010 |
Why?
|
Algorithms | 1 | 2013 | 13881 | 0.010 |
Why?
|
Hospitalization | 1 | 2009 | 10262 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35421 | 0.000 |
Why?
|
Reproducibility of Results | 1 | 2003 | 19905 | 0.000 |
Why?
|